Holdings
Virtus KAR Health Sciences Fund
As of Jun 30, 2026, Virtus KAR Health Sciences Fund reported 24 positions worth US$90.3M. Largest: Eli Lilly And Company, West Pharmaceutical Services, Inc. and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 11,348 | US$13.6M | −1,634 | Jun 30, 2026 |
| West Pharmaceutical Services, Inc. | 15,110 | US$5.42M | −651 | Jun 30, 2026 |
| Abbvie Inc. | 20,131 | US$5.07M | −869 | Jun 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 9,813 | US$4.87M | −423 | Jun 30, 2026 |
| Merck & Company, Inc. | 36,134 | US$4.64M | −1,560 | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 10,264 | US$4.27M | −442 | Jun 30, 2026 |
| Mckesson Corporation | 5,542 | US$4.19M | −239 | Jun 30, 2026 |
| Mettler-toledo International, Inc. | 2,865 | US$3.66M | −125 | Jun 30, 2026 |
| Intuitive Surgical, Inc. | 8,960 | US$3.56M | −387 | Jun 30, 2026 |
| Amgen Inc. | 9,757 | US$3.53M | −422 | Jun 30, 2026 |